ONCOTHERAPY SCIENCE LTD has a total of 45 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2005. It filed its patents most often in Japan. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are FUSO PHARMACEUTICAL INDUSTRIES LTD, ONCOTHERAPY SCIENCE INC and INST NAT SANTE RECH MED.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 45 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Environmental technology | |
#6 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Tsunoda Takuya | 32 |
#2 | Nakamura Yusuke | 27 |
#3 | Osawa Ryuji | 15 |
#4 | Nakazuru Shuichi | 14 |
#5 | Tawara Hideaki | 12 |
#6 | Furukawa Yoichi | 10 |
#7 | Daigo Yataro | 9 |
#8 | Watanabe Tomohisa | 9 |
#9 | Yoshimura Sachiko | 6 |
#10 | Yamashita Sachiko | 3 |
Publication | Filing date | Title |
---|---|---|
JP2017042047A | Vegfr2-derived peptide and vaccine comprising the same | |
JP2013176367A | Vegfr1-originated peptide and vaccine containing the same | |
JP2013176368A | Vegfr2-originated peptide and vaccine containing the same | |
JP2013176366A | Vegfr1-originated peptide and vaccine containing the same | |
JP2011195586A | Method for damaging cell using effector function of anti-gfra1 antibody | |
JP2011246389A | Condensed-ring pyrazole derivative having ttk inhibiting action | |
JP2012197231A | Pyridine and pyrimidine derivative having ttk-inhibiting action | |
JP2006052216A | Peptide vaccine for treatment of gastric cancer or colorectal cancer expressing cxadrl1 or gcud1 protein |